CDC42 and neoplasm: While constitutive deletion of cdc42 inhibits tumor formation and subsequent growth, to address the feasibility of targeting Cdc42 for therapeutic intervention in tumors driven by HRasV12 mutation, cdc42 was inducibly deleted in established tumors.